<PAGE> 1
Filed Pursuant to Rule 424(b)(3)
File No. 333-45825
PROSPECTUS SUPPLEMENT NO. 20 OMNICARE, INC.
(To Prospectus dated February 13, 1998)
The Prospectus dated February 13, 1998, as supplemented by Prospectus
Supplements 1 through 19, relates to the offer for resale of the following
securities of Omnicare, Inc.:
- $345,000,000 Principal Amount of 5% Convertible Subordinated
Debentures due 2007
- 8,712,121 shares of Common Stock, par value $1.00 per share,
that are issuable upon the conversion of the Debentures (plus
such additional amount as may result due to changes in the
conversion price)
- 264,101 additional shares of Common Stock, par value $1.00 per
share
ADDITIONAL SELLING SECURITYHOLDERS
The table beginning on page 22 of the Prospectus contained in the section
entitled "Selling Securityholders" is amended to add the following Selling
Securityholders:
<TABLE>
<CAPTION>
Principal Amount Percentage of Debentures Percentage of Common
of Debentures Outstanding Beneficially Conversion Shares Stock Beneficially
Name that May be Sold Owned Before Offering That May be Sold** Owned Before Offering
---- ---------------- ----------------------- ------------------ ---------------------
<S> <C> <C> <C> <C>
D.E. Shaw $500,000 * 12,626 *
Securities LP
Goldman, Sachs & 875,000 * 22,095 *
Co.
Highbridge Capital 3,000,000 * 75,757 *
Corporation
LDG Limited 500,000 * 12,626 *
TQA Arbitrage 2,000,000 * 50,505 *
Fund, L.P.
TQA Leverage 600,000 * 15,151 *
Fund, L.P.
TQA Vantage 3,500,000 1.0% 88,383 *
Fund, Ltd.
TQA Vantage Plus 400,000 * 10,101 *
Fund, Ltd.
<FN>
- -------------------
* Less than 1%
** Assumes conversion of full amount of Debentures held by the holder at the initial rate of $39.60 in principal amount of
Debentures per share of Common Stock.
</TABLE>
-1-
<PAGE> 2
DELIVERY OF PROSPECTUS SUPPLEMENT
This Prospectus Supplement is not complete without the Prospectus, as
supplemented prior to today. The additional selling securityholders named above
may only deliver this Prospectus Supplement with the Prospectus and all prior
supplements.
This Prospectus Supplement is dated November 23, 1998.
-2-
